收藏切换
Screening of Monoclonal Antibodies against Human CD40 and Antitumor Activity Evaluation of Humanized Antibodies
收藏切换
Lili ZHAO1, 2, Xiaoli ZHANG1, 2, Wenpeng ZHAO3, Zhongsong ZHU1, 2, Zhong LIU4, *
Chinese Journal of Pharmaceuticals | 2024, 55(1) : 58 - 65
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2024, 55(1): 58-65
• Paper •
Screening of Monoclonal Antibodies against Human CD40 and Antitumor Activity Evaluation of Humanized Antibodies
Full
Lili ZHAO1, 2, Xiaoli ZHANG1, 2, Wenpeng ZHAO3, Zhongsong ZHU1, 2, Zhong LIU4, *
Affiliations
  • 1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400
  • 2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400
  • 3.Shenyang Pharmaceutical University, Shenyang 110016
  • 4.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000
Published: 2024-01-10 doi: 10.16522/j.cnki.cjph.2024.01.007
Outline
收藏切换

Agonistic CD40 antibodies hold great potentials in the treatment of malignant tumors, yet their efficacy and safety remain to be fully established. This research identified and humanized two high-binding and high-affinity agonistic anti-CD40 monoclonal antibodies (31A2-2 and 42D11-8) via hybridoma technique, and evaluated their pharmacodynamics through the NPG mouse xenograft model. The results revealed that the modified antibodies maintained high binding affinity after measurement, and demonstrated robust activation capacity in dendritic cell activation assays, thereby stimulated dendritic cells to release IL-12. Both antibodies exhibited significant antitumor activities in NPG mice, with tumor growth inhibition rates reaching 86.83% and 87.95% respectively. This study provided data support for the development of agonistic CD40 drugs.

CD40 monoclonal antibody  /  hybridoma technique  /  humanized antibody  /  antitumor activity
赵丽丽, 张晓丽, 赵文鹏, 朱中松, 刘忠. 抗人CD40单克隆抗体的筛选及其人源化抗体的抗肿瘤活性评价. 中国医药工业杂志, 2024 , 55 (1) : 58 -65 . DOI: 10.16522/j.cnki.cjph.2024.01.007
Lili ZHAO, Xiaoli ZHANG, Wenpeng ZHAO, Zhongsong ZHU, Zhong LIU. Screening of Monoclonal Antibodies against Human CD40 and Antitumor Activity Evaluation of Humanized Antibodies[J]. Chinese Journal of Pharmaceuticals, 2024 , 55 (1) : 58 -65 . DOI: 10.16522/j.cnki.cjph.2024.01.007
Year 2024 volume 55 Issue 1
21
7
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2024.01.007
  • Receive Date:2023-01-08
  • Online Date:2026-11-19
  • Published:2024-01-10
Article Data
Affiliations
History
  • Received:2023-01-08
Funding
Affiliations
    1.Lunan New Time Bio-tech Co., Ltd., Linyi 273400
    2.State Engineering Lab. of High Expression of Mammalian Cells, Linyi 273400
    3.Shenyang Pharmaceutical University, Shenyang 110016
    4.Lunan Pharmaceutical Group Co., Ltd., Linyi 276000
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2024.01.007
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT